跳至主要内容
临床试验/NCT05094947
NCT05094947Unknown不适用

Indwelling Urinary Catheterization Versus Clean Intermittent Catheterization for the Management of Acute Urinary Retention: Multicenter, Randomized, Controlled Clinical Trial.

Moscow State University of Medicine and Dentistry1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2021年8月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
Assessment of the quality of life

研究概览

简要总结

This is a prospective, comparative, multicenter, randomized controlled trial. The aim of this study is to compare the efficacy, safety and quality of life within patients with acute urinary retention managed by the intermittent catheterization compared or indwelling Foley catheter.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 95 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Men with acute urinary retention due to prostatic hyperplasia

排除标准

  • Patient's with serious conditions and incapacity
  • Previous urethral or prostate surgery.
  • Urethral stricture.
  • Urethrorrhagia.
  • Injuries of urethra and perineum.
  • Attempts of bladder catheterization within 15 days before the acute urinary retention episode.
  • Urinary tract infection.
  • Neurogenic bladder.
  • Chronic urinary retention with a bladder volume of more than 1 liter.
  • Obstructive uropathy due to the acute urinary retention.

研究组 & 干预措施

intermittent catheterization (group B)

Experimental

Procedure/Surgery: The acute urinary retention in group B is managed by clean intermittent catheterization along with alpha-blockers during 3 period. After 3 days the ability of spontaneous voiding is assessed and registered as an outcome.

干预措施: intermittent catheterization (Procedure)

intermittent catheterization (group B)

Experimental

Procedure/Surgery: The acute urinary retention in group B is managed by clean intermittent catheterization along with alpha-blockers during 3 period. After 3 days the ability of spontaneous voiding is assessed and registered as an outcome.

干预措施: alpha-blockers (Drug)

Catheter Foley (group A)

Active Comparator

The acute urinary retention in group A is managed by trial without catheter along with alpha-blockers during 3 period. After 3 days the indwelling Foley catheter is removed and ability of spontaneous voiding is assessed and registered as an outcome.

干预措施: trial without catheter (Procedure)

Catheter Foley (group A)

Active Comparator

The acute urinary retention in group A is managed by trial without catheter along with alpha-blockers during 3 period. After 3 days the indwelling Foley catheter is removed and ability of spontaneous voiding is assessed and registered as an outcome.

干预措施: alpha-blockers (Drug)

结局指标

主要结局

Assessment of the quality of life

时间窗: 2 months

Assessment of the quality of life according to the SF-36 questionnaire on the first, second, or third day after the start of intermittent catheterization

次要结局

  • Assessment of the restoration of self-urination.(2 months)

研究者

发起方
Moscow State University of Medicine and Dentistry
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验